Defining Antiretroviral Pharmacology Within HIV-1 Reservoirs of Males and Females
Latest Information Update: 02 Jan 2023
At a glance
- Drugs Dolutegravir (Primary) ; Abacavir/dolutegravir/lamivudine; Emtricitabine/tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Pharmacokinetics
- 13 Aug 2021 Status changed from suspended to discontinued early due to the ongoing covid-19 pandemic making it unsafe to recruitparticipants for in-person visits. Participants are living with HIV who are antiretroviraltherapy-naive and are at high risk of covid-19 complications.
- 19 Nov 2020 Planned End Date changed from 1 Oct 2020 to 1 May 2021.
- 19 Nov 2020 Planned primary completion date changed from 1 Oct 2020 to 1 May 2021.